CPIG
TRML

Chicago Partners Investment Group’s Tourmaline Bio TRML Stock Holding History

Chicago Partners Investment Group’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,483
Closed -$26.2K – 689
2022
Q4 		$26.2K Buy
+1,483
New +$23.8K ﹤0.01% 635

Other funds holding TRML

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Chicago Partners Investment Group's TRML Position: Q1 2023 in Review

Chicago Partners Investment Group sold out of Tourmaline Bio (TRML) in Q1 2023, closing a stake of 1,483 shares — an estimated $26.2K sold.

Chicago Partners Investment Group first reported a position in TRML in Q4 2022 and held it in 1 quarter. The position peaked at $26.2K in Q4 2022. 54 funds tracked by Wall St. Rank hold TRML as of Q1 2023.

  • Chicago Partners Investment Group reported no remaining Tourmaline Bio position as of Q1 2023 after selling out during the quarter.
  • Chicago Partners Investment Group sold 1,483 Tourmaline Bio shares in Q1 2023, an estimated $26.2K.
  • Chicago Partners Investment Group first reported a position in Tourmaline Bio in Q4 2022 and held it in 1 quarter.
  • Chicago Partners Investment Group's Tourmaline Bio position peaked at $26.2K in Q4 2022.
  • 54 funds tracked by Wall St. Rank held Tourmaline Bio as of Q1 2023.

Based on Chicago Partners Investment Group's 13F filing for Q1 2023, filed 26 Apr 2023.